Bliss GVS Pharma Limited (BOM:506197)
510.55
+22.86 (4.69%)
At close: Jul 7, 2026
Bliss GVS Pharma Company Description
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally.
The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services.
It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Bliss GVS Pharma Limited
| Country | India |
| Founded | 1984 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,033 |
| CEO | Shibroor Kamath |
Contact Details
Address: 102, Hyde Park Mumbai, Maharashtra 400072 India | |
| Phone | 91 22 4216 0000 |
| Website | blissgvs.com |
Stock Details
| Ticker Symbol | 506197 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shibroor Kamath | Chief Executive Officer |
| Deepak Sawant | Chief Financial Officer |